regent pharmaceuticals limited
regent pharmaceuticals limited Company Information
Company Number
08792581
Website
www.regentpharma.co.ukRegistered Address
50 vectis road vectis road, london, SW17 9RG
Industry
Private security activities
Wholesale of perfume and cosmetics
Telephone
02085952444
Next Accounts Due
15 days late
Group Structure
View All
Directors
Omar Farooqui3 Years
Shareholders
omar farooqui 57.5%
sofia farooqui 42.5%
regent pharmaceuticals limited Estimated Valuation
Pomanda estimates the enterprise value of REGENT PHARMACEUTICALS LIMITED at £22.3k based on a Turnover of £60k and 0.37x industry multiple (adjusted for size and gross margin).
regent pharmaceuticals limited Estimated Valuation
Pomanda estimates the enterprise value of REGENT PHARMACEUTICALS LIMITED at £0 based on an EBITDA of £0 and a 2.93x industry multiple (adjusted for size and gross margin).
regent pharmaceuticals limited Estimated Valuation
Pomanda estimates the enterprise value of REGENT PHARMACEUTICALS LIMITED at £29 based on Net Assets of £41 and 0.72x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Regent Pharmaceuticals Limited Overview
Regent Pharmaceuticals Limited is a live company located in london, SW17 9RG with a Companies House number of 08792581. It operates in the wholesale of perfume and cosmetics sector, SIC Code 46450. Founded in November 2013, it's largest shareholder is omar farooqui with a 57.5% stake. Regent Pharmaceuticals Limited is a established, micro sized company, Pomanda has estimated its turnover at £60k with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Regent Pharmaceuticals Limited Health Check
Pomanda's financial health check has awarded Regent Pharmaceuticals Limited a 1 rating. We use a traffic light system to show it exceeds the industry average on 1 measures and has 5 areas for improvement. Company Health Check FAQs
1 Strong
1 Regular
5 Weak
Size
annual sales of £60k, make it smaller than the average company (£14.2m)
- Regent Pharmaceuticals Limited
£14.2m - Industry AVG
Growth
3 year (CAGR) sales growth of -76%, show it is growing at a slower rate (2.5%)
- Regent Pharmaceuticals Limited
2.5% - Industry AVG
Production
with a gross margin of 17%, this company has a higher cost of product (28.1%)
- Regent Pharmaceuticals Limited
28.1% - Industry AVG
Profitability
There is insufficient data available for this Key Performance Indicator!
- Regent Pharmaceuticals Limited
- - Industry AVG
Employees
with 1 employees, this is below the industry average (47)
1 - Regent Pharmaceuticals Limited
47 - Industry AVG
Pay Structure
on an average salary of £43.9k, the company has an equivalent pay structure (£43.9k)
- Regent Pharmaceuticals Limited
£43.9k - Industry AVG
Efficiency
resulting in sales per employee of £60k, this is less efficient (£365.2k)
- Regent Pharmaceuticals Limited
£365.2k - Industry AVG
Debtor Days
it gets paid by customers after 0 days, this is earlier than average (54 days)
- Regent Pharmaceuticals Limited
54 days - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- Regent Pharmaceuticals Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Regent Pharmaceuticals Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Regent Pharmaceuticals Limited
- - Industry AVG
Debt Level
There is insufficient data available for this Key Performance Indicator!
- - Regent Pharmaceuticals Limited
- - Industry AVG
REGENT PHARMACEUTICALS LIMITED financials
Regent Pharmaceuticals Limited's latest turnover from November 2022 is estimated at £60 thousand and the company has net assets of £41. According to their latest financial statements, Regent Pharmaceuticals Limited has 1 employee and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Nov 2022 | Nov 2021 | Nov 2020 | Nov 2019 | Nov 2018 | Nov 2017 | Nov 2016 | Nov 2015 | Nov 2014 | |
|---|---|---|---|---|---|---|---|---|---|
| Turnover | |||||||||
| Other Income Or Grants | |||||||||
| Cost Of Sales | |||||||||
| Gross Profit | |||||||||
| Admin Expenses | |||||||||
| Operating Profit | |||||||||
| Interest Payable | |||||||||
| Interest Receivable | |||||||||
| Pre-Tax Profit | |||||||||
| Tax | |||||||||
| Profit After Tax | |||||||||
| Dividends Paid | |||||||||
| Retained Profit | |||||||||
| Employee Costs | |||||||||
| Number Of Employees | 1 | 1 | 7 | ||||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Nov 2022 | Nov 2021 | Nov 2020 | Nov 2019 | Nov 2018 | Nov 2017 | Nov 2016 | Nov 2015 | Nov 2014 | |
|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 20 | 20 | 197,472 | 183,122 | 208,746 | 26,639 | 99,829 | 7,774 | 8,450 |
| Intangible Assets | 0 | 0 | 3,739 | 12,474 | 0 | 0 | 0 | 2,095 | 3,142 |
| Investments & Other | 1 | 1 | 36,000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 21 | 21 | 237,211 | 195,596 | 208,746 | 26,639 | 99,829 | 9,869 | 11,592 |
| Stock & work in progress | 0 | 0 | 572,375 | 120,000 | 0 | 0 | 0 | 6,545 | 2,551 |
| Trade Debtors | 20 | 20 | 486,329 | 1,174,172 | 1,286,983 | 950,071 | 854,972 | 149,375 | 10,658 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 0 | 0 | 82,185 | 479,756 | 0 | 0 | 0 | 48,808 | 1,377 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 20 | 20 | 1,140,889 | 1,773,928 | 1,286,983 | 950,071 | 854,972 | 204,728 | 14,586 |
| total assets | 41 | 41 | 1,378,100 | 1,969,524 | 1,495,729 | 976,710 | 954,801 | 214,597 | 26,178 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 0 | 0 | 739,106 | 1,289,951 | 894,537 | 757,468 | 374,382 | 106,010 | 22,710 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current liabilities | 0 | 0 | 739,106 | 1,289,951 | 894,537 | 757,468 | 374,382 | 106,010 | 22,710 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 329,735 | 329,735 | 329,735 | 329,735 | 359,674 | 79,850 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 0 | 0 | 329,735 | 329,735 | 329,735 | 329,735 | 359,674 | 79,850 | 0 |
| total liabilities | 0 | 0 | 1,068,841 | 1,619,686 | 1,224,272 | 1,087,203 | 734,056 | 185,860 | 22,710 |
| net assets | 41 | 41 | 309,259 | 349,838 | 271,457 | -110,493 | 220,745 | 28,737 | 3,468 |
| total shareholders funds | 41 | 41 | 309,259 | 349,838 | 271,457 | -110,493 | 220,745 | 28,737 | 3,468 |
| Nov 2022 | Nov 2021 | Nov 2020 | Nov 2019 | Nov 2018 | Nov 2017 | Nov 2016 | Nov 2015 | Nov 2014 | |
|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||
| Operating Profit | |||||||||
| Depreciation | 0 | 0 | 0 | 3,524 | 2,816 | ||||
| Amortisation | 0 | 0 | 0 | 1,047 | 1,047 | ||||
| Tax | |||||||||
| Stock | 0 | -572,375 | 452,375 | 120,000 | 0 | 0 | -6,545 | 3,994 | 2,551 |
| Debtors | 0 | -486,309 | -687,843 | -112,811 | 336,912 | 95,099 | 705,597 | 138,717 | 10,658 |
| Creditors | 0 | -739,106 | -550,845 | 395,414 | 137,069 | 383,086 | 268,372 | 83,300 | 22,710 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | |||||||||
| Investing Activities | |||||||||
| capital expenditure | |||||||||
| Change in Investments | 0 | -35,999 | 36,000 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | |||||||||
| Financing Activities | |||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | -329,735 | 0 | 0 | 0 | -29,939 | 279,824 | 79,850 | 0 |
| share issue | |||||||||
| interest | |||||||||
| cash flow from financing | |||||||||
| cash and cash equivalents | |||||||||
| cash | 0 | -82,185 | -397,571 | 479,756 | 0 | 0 | -48,808 | 47,431 | 1,377 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | 0 | -82,185 | -397,571 | 479,756 | 0 | 0 | -48,808 | 47,431 | 1,377 |
regent pharmaceuticals limited Credit Report and Business Information
Regent Pharmaceuticals Limited Competitor Analysis
Perform a competitor analysis for regent pharmaceuticals limited by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other micro companies, companies in SW17 area or any other competitors across 12 key performance metrics.
regent pharmaceuticals limited Ownership
REGENT PHARMACEUTICALS LIMITED group structure
Regent Pharmaceuticals Limited has no subsidiary companies.
Ultimate parent company
REGENT PHARMACEUTICALS LIMITED
08792581
regent pharmaceuticals limited directors
Regent Pharmaceuticals Limited currently has 1 director, Mr Omar Farooqui serving since Jun 2021.
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Omar Farooqui | England | 49 years | Jun 2021 | - | Director |
P&L
November 2022turnover
60k
+12%
operating profit
0
0%
gross margin
17%
+11.97%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
November 2022net assets
41
0%
total assets
41
0%
cash
0
0%
net assets
Total assets minus all liabilities
Similar Companies
regent pharmaceuticals limited company details
company number
08792581
Type
Private limited with Share Capital
industry
46460 - Wholesale of pharmaceutical goods
80100 - Private security activities
46450 - Wholesale of perfume and cosmetics
incorporation date
November 2013
age
11
incorporated
UK
accounts
Micro-Entity Accounts
ultimate parent company
previous names
N/A
last accounts submitted
November 2022
address
50 vectis road vectis road, london, SW17 9RG
accountant
-
auditor
-
regent pharmaceuticals limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to regent pharmaceuticals limited.
regent pharmaceuticals limited Companies House Filings - See Documents
| date | description | view/download |
|---|
